0001209191-24-002949.txt : 20240206 0001209191-24-002949.hdr.sgml : 20240206 20240206202051 ACCESSION NUMBER: 0001209191-24-002949 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240205 FILED AS OF DATE: 20240206 DATE AS OF CHANGE: 20240206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shukla Sanjay CENTRAL INDEX KEY: 0001671026 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37378 FILM NUMBER: 24601823 MAIL ADDRESS: STREET 1: C/O ATYR PHARMA, INC. STREET 2: 10240 SORRENTO VALLEY ROAD, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: aTYR PHARMA INC CENTRAL INDEX KEY: 0001339970 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 203435077 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10240 SORRENTO VALLEY ROAD STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8587318389 MAIL ADDRESS: STREET 1: 10240 SORRENTO VALLEY ROAD STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-02-05 0 0001339970 aTYR PHARMA INC LIFE 0001671026 Shukla Sanjay 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 1 1 0 0 President and CEO 0 Common stock 2024-02-05 4 M 0 10375 A 116548 D Restricted Stock Unit 2024-02-05 4 M 0 10375 0.00 D Common Stock 10375 20750 D Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022. Restricted stock units convert into common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. /s/ Nancy E. Denyes, attorney-in-fact 2024-02-06